ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/01 | 1,428 | 1,435 | 1,395 | 1,422 | -19 | -1.3% | 1,335,600 |
| 2024/01/31 | 1,421 | 1,442 | 1,413 | 1,441 | -3 | -0.2% | 798,500 |
| 2024/01/30 | 1,445 | 1,450 | 1,414 | 1,444 | +2 | +0.1% | 933,100 |
| 2024/01/29 | 1,414 | 1,465 | 1,412 | 1,442 | +22 | +1.5% | 1,047,900 |
| 2024/01/26 | 1,506 | 1,506 | 1,420 | 1,420 | -93 | -6.1% | 2,335,500 |
| 2024/01/25 | 1,458 | 1,513 | 1,448 | 1,513 | +54 | +3.7% | 1,339,900 |
| 2024/01/24 | 1,430 | 1,465 | 1,426 | 1,459 | +26 | +1.8% | 1,009,100 |
| 2024/01/23 | 1,463 | 1,467 | 1,428 | 1,433 | -31 | -2.1% | 752,400 |
| 2024/01/22 | 1,443 | 1,467 | 1,423 | 1,464 | +24 | +1.7% | 758,700 |
| 2024/01/19 | 1,430 | 1,457 | 1,424 | 1,440 | +14 | +1% | 910,900 |
| 2024/01/18 | 1,433 | 1,436 | 1,408 | 1,426 | +4 | +0.3% | 1,093,800 |
| 2024/01/17 | 1,506 | 1,518 | 1,420 | 1,422 | -106 | -6.9% | 2,715,500 |
| 2024/01/16 | 1,530 | 1,533 | 1,506 | 1,528 | ±0 | ±0% | 687,200 |
| 2024/01/15 | 1,540 | 1,549 | 1,515 | 1,528 | -24 | -1.5% | 997,400 |
| 2024/01/12 | 1,599 | 1,623 | 1,548 | 1,552 | -38 | -2.4% | 1,235,700 |
| 2024/01/11 | 1,572 | 1,608 | 1,559 | 1,590 | +30 | +1.9% | 1,609,700 |
| 2024/01/10 | 1,523 | 1,572 | 1,516 | 1,560 | +41 | +2.7% | 1,463,900 |
| 2024/01/09 | 1,525 | 1,539 | 1,478 | 1,519 | +9 | +0.6% | 1,919,500 |
| 2024/01/05 | 1,466 | 1,530 | 1,458 | 1,510 | +49 | +3.4% | 2,233,700 |
| 2024/01/04 | 1,425 | 1,467 | 1,400 | 1,461 | +40 | +2.8% | 1,176,900 |
| 2023/12/29 | 1,436 | 1,462 | 1,419 | 1,421 | -32 | -2.2% | 808,900 |
| 2023/12/28 | 1,450 | 1,460 | 1,429 | 1,453 | +28 | +2% | 904,400 |
| 2023/12/27 | 1,364 | 1,425 | 1,348 | 1,425 | +59 | +4.3% | 1,560,800 |
| 2023/12/26 | 1,370 | 1,383 | 1,355 | 1,366 | -8 | -0.6% | 1,028,300 |
| 2023/12/25 | 1,375 | 1,394 | 1,366 | 1,374 | -1 | -0.1% | 617,200 |
| 2023/12/22 | 1,399 | 1,415 | 1,369 | 1,375 | -23 | -1.6% | 1,086,500 |
| 2023/12/21 | 1,408 | 1,413 | 1,394 | 1,398 | -25 | -1.8% | 760,300 |
| 2023/12/20 | 1,427 | 1,463 | 1,405 | 1,423 | +11 | +0.8% | 1,111,900 |
| 2023/12/19 | 1,420 | 1,441 | 1,389 | 1,412 | -5 | -0.4% | 1,238,200 |
| 2023/12/18 | 1,420 | 1,439 | 1,407 | 1,417 | -8 | -0.6% | 905,700 |
| 2023/12/15 | 1,423 | 1,443 | 1,412 | 1,425 | +13 | +0.9% | 1,043,700 |
| 2023/12/14 | 1,447 | 1,461 | 1,393 | 1,412 | -10 | -0.7% | 1,254,100 |
| 2023/12/13 | 1,411 | 1,430 | 1,388 | 1,422 | +6 | +0.4% | 834,200 |
| 2023/12/12 | 1,425 | 1,429 | 1,404 | 1,416 | -10 | -0.7% | 669,200 |
| 2023/12/11 | 1,432 | 1,437 | 1,402 | 1,426 | ±0 | ±0% | 694,000 |
| 2023/12/08 | 1,465 | 1,487 | 1,416 | 1,426 | -65 | -4.4% | 1,533,000 |
| 2023/12/07 | 1,499 | 1,523 | 1,461 | 1,491 | -2 | -0.1% | 1,430,900 |
| 2023/12/06 | 1,440 | 1,493 | 1,440 | 1,493 | +62 | +4.3% | 1,433,200 |
| 2023/12/05 | 1,450 | 1,455 | 1,422 | 1,431 | -9 | -0.6% | 1,002,600 |
| 2023/12/04 | 1,434 | 1,462 | 1,413 | 1,440 | +22 | +1.6% | 1,388,300 |
| 2023/12/01 | 1,419 | 1,430 | 1,399 | 1,418 | +29 | +2.1% | 953,600 |
| 2023/11/30 | 1,382 | 1,409 | 1,372 | 1,389 | -8 | -0.6% | 1,915,200 |
| 2023/11/29 | 1,434 | 1,462 | 1,394 | 1,397 | -137 | -8.9% | 3,654,300 |
| 2023/11/28 | 1,461 | 1,534 | 1,440 | 1,534 | +76 | +5.2% | 1,375,100 |
| 2023/11/27 | 1,430 | 1,478 | 1,420 | 1,458 | +6 | +0.4% | 1,372,800 |
| 2023/11/24 | 1,507 | 1,519 | 1,431 | 1,452 | -59 | -3.9% | 3,022,100 |
| 2023/11/22 | 1,500 | 1,539 | 1,473 | 1,511 | +26 | +1.8% | 1,658,400 |
| 2023/11/21 | 1,463 | 1,514 | 1,428 | 1,485 | +82 | +5.8% | 2,516,600 |
| 2023/11/20 | 1,364 | 1,434 | 1,364 | 1,403 | +40 | +2.9% | 1,356,600 |
| 2023/11/17 | 1,330 | 1,366 | 1,312 | 1,363 | +13 | +1% | 1,751,700 |
351～
400
件表示中 / 5127件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 84,400円 | +20.3% | - | 0.00% | 149.65倍 | 1.11倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 146,800円 | -2.4% | -52.3% | 3.88% | 17.57倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 208,400円 | +4.1% | -3.1% | 2.78% | 18.07倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ハートシード | 323,000円 | +174.2% | - | 0.00% | - | 9.69倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| あすかＨＤ | 246,900円 | +16.9% | +33.2% | 2.23% | 13.47倍 | 1.07倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
